These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21956898)

  • 1. Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient.
    Chang T; Zheng W; Tsark W; Bates S; Huang H; Lin RJ; Yee JK
    Stem Cells; 2011 Dec; 29(12):2090-3. PubMed ID: 21956898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of proximal autosomal recessive spinal muscular atrophy.
    Simic G
    Acta Neuropathol; 2008 Sep; 116(3):223-34. PubMed ID: 18629520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.
    Garcera A; Mincheva S; Gou-Fabregas M; Caraballo-Miralles V; Lladó J; Comella JX; Soler RM
    Neurobiol Dis; 2011 Jun; 42(3):415-26. PubMed ID: 21333739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death of motoneurons induced by trophic deprivation or by excitotoxicity is not prevented by overexpression of SMN.
    Cisterni C; Kallenbach S; Jordier F; Bagnis C; Pettmann B
    Neurobiol Dis; 2001 Apr; 8(2):240-51. PubMed ID: 11300720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
    Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ
    Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation.
    Farooq F; Abadía-Molina F; MacKenzie D; Hadwen J; Shamim F; O'Reilly S; Holcik M; MacKenzie A
    Hum Mol Genet; 2013 Sep; 22(17):3415-24. PubMed ID: 23656793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential SMN interacting protein (SIP1) is not involved in the phenotypic variability of spinal muscular atrophy (SMA).
    Helmken C; Wetter A; Rudnik-Schöneborn S; Liehr T; Zerres K; Wirth B
    Eur J Hum Genet; 2000 Jul; 8(7):493-9. PubMed ID: 10909848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental abnormalities in neurosphere-derived neural stem cells from SMN-depleted mice.
    Shafey D; MacKenzie AE; Kothary R
    J Neurosci Res; 2008 Oct; 86(13):2839-47. PubMed ID: 18521935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin.
    Nölle A; Zeug A; van Bergeijk J; Tönges L; Gerhard R; Brinkmann H; Al Rayes S; Hensel N; Schill Y; Apkhazava D; Jablonka S; O'mer J; Srivastav RK; Baasner A; Lingor P; Wirth B; Ponimaskin E; Niedenthal R; Grothe C; Claus P
    Hum Mol Genet; 2011 Dec; 20(24):4865-78. PubMed ID: 21920940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell-derived neurotrophic support for the neuromuscular junction in spinal muscular atrophy.
    Wyatt TJ; Keirstead HS
    Expert Opin Biol Ther; 2010 Nov; 10(11):1587-94. PubMed ID: 20955113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs.
    Yoshida M; Kitaoka S; Egawa N; Yamane M; Ikeda R; Tsukita K; Amano N; Watanabe A; Morimoto M; Takahashi J; Hosoi H; Nakahata T; Inoue H; Saito MK
    Stem Cell Reports; 2015 Apr; 4(4):561-8. PubMed ID: 25801509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
    Liu H; Beauvais A; Baker AN; Tsilfidis C; Kothary R
    Dev Neurobiol; 2011 Feb; 71(2):153-69. PubMed ID: 20862739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy.
    Xu CC; Denton KR; Wang ZB; Zhang X; Li XJ
    Dis Model Mech; 2016 Jan; 9(1):39-49. PubMed ID: 26586529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons.
    Rossoll W; Jablonka S; Andreassi C; Kröning AK; Karle K; Monani UR; Sendtner M
    J Cell Biol; 2003 Nov; 163(4):801-12. PubMed ID: 14623865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons.
    Boza-Morán MG; Martínez-Hernández R; Bernal S; Wanisch K; Also-Rallo E; Le Heron A; Alías L; Denis C; Girard M; Yee JK; Tizzano EF; Yáñez-Muñoz RJ
    Sci Rep; 2015 Jun; 5():11696. PubMed ID: 26114395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HuD and the Survival Motor Neuron Protein Interact in Motoneurons and Are Essential for Motoneuron Development, Function, and mRNA Regulation.
    Hao le T; Duy PQ; An M; Talbot J; Iyer CC; Wolman M; Beattie CE
    J Neurosci; 2017 Nov; 37(48):11559-11571. PubMed ID: 29061699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMN deficiency attenuates migration of U87MG astroglioma cells through the activation of RhoA.
    Caraballo-Miralles V; Cardona-Rossinyol A; Garcera A; Villalonga P; Soler RM; Olmos G; Lladó J
    Mol Cell Neurosci; 2012 Mar; 49(3):282-9. PubMed ID: 22197680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.